Nantahala Capital Management, LLC
CIK 1472322 · last filed 2025-01-30
Nantahala Capital Management, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing shows the insider sold $540 of EVOK on Jan 30, 2025. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
5
-$1.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc (EVOK) Delisted | 10%+ Owner | 148,153 | $11.00 | $1.63M | -$540 | 1 | 2025-01-30 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | 10%+ Owner | 275,640 | — | — | -$1.81M | 1 | 2012-04-24 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-30 | Evoke Pharma Inc (EVOK) Delisted | Sell (S) | −123 | -$540 | EDGAR |
| 2022-07-15 | — | Other (J) | — | $0 | |
| 2022-07-15 | — | Other (J) | — | $0 | |
| 2020-11-16 | — | Mixed | — | $0 | |
| 2012-04-24 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Sell (S) | −219,900 | -$1.81M | EDGAR |